StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Kiora Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Kiora Pharmaceuticals's price to sales ratio was 390.1× on Jul 31, 2025, against 0.8× a year earlier. Over the last 5 years it ranged from 0.6× to 478.8×, with a median of 101.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 2025390.1×+389.5
2024Dec 31, 20240.6×−7.1
2020Apr 30, 20207.7×−3.3
2019Dec 31, 201911.1×−167.9
2018Dec 31, 2018178.9×−295.4
2017Dec 29, 2017474.4×+25.1
2016Dec 30, 2016449.3×–

More Kiora Pharmaceuticals figures

See a number that looks wrong?